Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
54.48
+1.04 (1.95%)
At close: Oct 24, 2025, 4:00 PM EDT
54.56
+0.08 (0.15%)
After-hours: Oct 24, 2025, 6:43 PM EDT

Revolution Medicines Stock Forecast

Stock Price Forecast

The 16 analysts that cover Revolution Medicines stock have a consensus rating of "Strong Buy" and an average price target of $76.63, which forecasts a 40.66% increase in the stock price over the next year. The lowest target is $64 and the highest is $99.

Price Target: $76.63 (+40.66%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$64$76.63$75$99
Change+17.47%+40.66%+37.67%+81.72%

Analyst Ratings

The average analyst rating for Revolution Medicines stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy7787910
Buy555676
Hold000000
Sell000000
Strong Sell000000
Total121213131616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho
Mizuho
Buy
Initiates
$90
BuyInitiates$90+65.20%Oct 21, 2025
Raymond James
Raymond James
Strong Buy
Maintains
$72$76
Strong BuyMaintains$72$76+39.50%Oct 17, 2025
Wedbush
Wedbush
Buy
Reiterates
$77
BuyReiterates$77+41.34%Oct 17, 2025
Stifel
Stifel
Strong Buy
Initiates
$85
Strong BuyInitiates$85+56.02%Oct 16, 2025
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$65$73
Strong BuyMaintains$65$73+33.99%Sep 12, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
4.31M
Revenue Next Year
24.25M
from 4.31M
Increased by 462.53%
EPS This Year
-5.41
from -3.58
EPS Next Year
-6.02
from -5.41
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
42.98M29.39M35.38M11.58M-4.31M24.25M
Revenue Growth
-14.10%-31.62%20.38%-67.27%--462.53%
EPS
-2.01-2.57-3.08-3.86-3.58-5.41-6.02
EPS Growth
-------
Forward PE
-------
No. Analysts
-----2020
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High43.8M149.6M
Avg4.3M24.2M
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High-
3,371.7%
Avg-
462.5%
Low--

EPS Forecast

EPS20252026202720282029
High-4.92-4.69
Avg-5.41-6.02
Low-5.51-7.54

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.